Trials / Completed
CompletedNCT02913287
Seaweed-Derived Mineral-Rich Nutraceuticals in Cognition
A Randomised, Double-blind, Placebo-controlled Study of the Cognitive-Enhancing Potential of Seaweed-Derived Mineral-Rich Nutraceuticals (a Combination of Aquamin F and Aquamin MG)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University College Cork · Academic / Other
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The aim of the overall project is to investigate the potential of a combination of commercially available nutraceuticals produced by Marigot Ltd (natural seawater derived mineral-rich AquaminMG and seaweed-derived mineral-rich food supplement AquaminTM (FDA GRAS 000028) isolated from Lithothamnion species), as safe and effective supplements to promote cognition in the aged brain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Aquamin/Aquamin MG | Marine-based nutraceutical |
| OTHER | Maltodextrin Placebo | Maltodextrin Placebo |
Timeline
- Start date
- 2015-10-15
- Primary completion
- 2016-11-09
- Completion
- 2017-01-01
- First posted
- 2016-09-23
- Last updated
- 2024-06-27
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT02913287. Inclusion in this directory is not an endorsement.